Xconomy: alirocumab News, Articles and Opinions

“alirocumab” Archives

Entry	Author	Date	Location
East Coast Biotech Roundup: Regeneron, Synergy, Foundation & More	Ben Fidler	07/31/15	Boston
Sanofi, Regeneron Set Sights on Immuno-Oncology With New $2B+ Pact	Ben Fidler	07/28/15	New York
Beer Out as Struggling Aegerion Shuffles Leadership Ranks	Ben Fidler	07/27/15	Boston
FDA OKs Cholesterol Fighter Praluent For More Patients Than Expected	Alex Lash	07/24/15	New York
East Coast Biotech Roundup: Biogen, RaNA, Inotek, Disruptors & More	Ben Fidler	07/24/15	Boston
With PCSK9’s Origins In Mind, Sanofi Has UT Join Funding Program	David Holley	07/09/15	Texas
FDA Cuts Limit on Esperion Cholesterol Drug, Considers Competitors	David Holley	07/07/15	Detroit Ann Arbor
East Coast Biotech Roundup: XTuit, Spero, Unum, RNAi Feud & More	Ben Fidler	06/12/15	Boston
Rare Heart Disease Advocate: “I’m More Relieved Than I’ve Ever Been”	Alex Lash	06/10/15	National
Advisors to FDA: Approve New Cholesterol Drug, But With Caveats	Alex Lash	06/10/15	National
Take a Grain of Salt (Or Two) With New Cholesterol Drug Predictions	Alex Lash	06/09/15	National
East Coast Biotech Roundup: Sync Project, Epizyme, Bristol & More	Ben Fidler	03/16/15	Boston
East Coast Biotech Roundup: Yumanity, Biogen, Blizzards, & More	Ben Fidler	01/30/15	Boston
With Gilead’s $125M Purchase, FDA Voucher Program Gains Momentum	Alex Lash	11/19/14	San Francisco
An Intriguing Program Takes on Tropical Diseases—But Not Ebola	Alex Lash	09/10/14	National
East Coast Biotech Roundup: Emulate, Accelerator, Retrophin, & More	Ben Fidler	08/01/14	Boston
Regeneron, Sanofi Drug Holds Up in Eczema Study	Ben Fidler	07/09/14	New York
East Coast Biotech Roundup: Schenkein, PureTech/JDRF, Sage, & More	Ben Fidler	10/18/13	Boston
Regeneron, Sanofi Pass First Key Test With Cholesterol-Lowering Drug	Ben Fidler	10/16/13	New York
Page 2 of 2	« previous page